Evaluation of ¹⁷⁷Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|9|1|64-70

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.9, Iss.1, 2015-11, pp. : 64-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic, Dosimetry and Toxicity Study of ¹⁷⁷Lu-EDTMP in Patients: Phase 0/I study

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 71-84

Bentham Science Publishers

Access to resources Recommend Favorite

Radiation Dosimetry Aspects of ¹⁷⁷Lu

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 139-144

Bentham Science Publishers

Access to resources Recommend Favorite

Consequences of meta-stable ^177mLu admixture in ¹⁷⁷Lu for patient dosimetry

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 145-149

Bentham Science Publishers

Access to resources Recommend Favorite

¹⁷⁷Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 85-93

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative method to determine Specific Activity of ¹⁷⁷Lu by HPLC

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 119-122

Bentham Science Publishers

Access to resources Recommend Favorite